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Abstract: The antinociceptive and anti-inflammatory activity of caulerpin was 
investigated. This bisindole alkaloid was isolated from the lipoid extract of Caulerpa 
racemosa and its structure was identified by spectroscopic methods, including IR and 
NMR techniques. The pharmacological assays used were the writhing and the hot plate 
tests, the formalin-induced pain, the capsaicin-induced ear edema and the carrageenan-
induced peritonitis. Caulerpin was given orally at a concentration of 100 µmol/kg. In the 
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abdominal constriction test caulerpin showed reduction in the acetic acid-induced 
nociception at 0.0945 μmol (0.0103–1.0984) and for dypirone it was 0.0426 μmol  
(0.0092–0.1972). In the hot plate test in vivo the inhibition of nociception by caulerpin  
(100 μmol/kg, p.o.) was also favorable. This result suggests that this compound exhibits a 
central activity, without changing the motor activity (seen in the rotarod test). Caulerpin 
(100  μmol/kg, p.o.) reduced the formalin effects in both phases by 35.4% and 45.6%, 
respectively. The possible anti-inflammatory activity observed in the second phase in the 
formalin test of caulerpin (100 μmol/kg, p.o.) was confirmed on the capsaicin-induced ear 
edema model, where an inhibition of 55.8% was presented. Indeed, it was also observed in 
the carrageenan-induced peritonitis that caulerpin (100 μmol/kg, p.o.) exhibited   
anti-inflammatory activity, reducing significantly the number of recruit cells by 48.3%. 
Pharmacological studies are continuing in order to characterize the mechanism(s) 
responsible for the antinociceptive and anti-inflammatory actions and also to identify other 
active principles present in Caulerpa racemosa.  
 
Keywords: Caulerpa racemosa; antinociceptive; anti-inflammatory; caulerpin 
 
1. Introduction 
 
Among the many chemical classes present in plant species, alkaloids stand out as one of major 
importance in the development of new drugs, because they possess a wide variety of chemical 
structures and have been identified as responsible for many of the pharmacological properties of 
medicinal plants [1–5]. Some plant families have the genetic capability of producing more than one 
alkaloid, reflected in the structural diversity of these compounds [6–8]. 
Indole compounds constitute an extensive family of chemicals found in bacteria, plants and 
animals. In general, these compounds are related to the metabolism of tryptophan and present 
substitutions in different positions of the indole ring [6,9]. Indolic compounds with significant and 
complex physiological roles include those related to melatonin and serotonin (5-hydroxytryptamine). 
Indole alkaloids possess an indole ring in its structure, constituting a versatile heterocyclic discovery in 
1866 [6]; this extensive group of alkaloids received more attention after the isolation of reserpine from 
Rauwolfia serpentina Benth., an alkaloid that changed the history of pathologies conditions as diverse 
as schizophrenia and hypertension. Indolic alkaloids include various plant-derived medicinal products, 
including the well-known anti-tumor vinblastine, vincristine, vincamin isolated from Catharanthus 
roseus [10] and camptothecin, is a monoterpene indole alkaloid isolated from the Chinese tree 
Camptotheca acuminate Decne. (Icacinaceae) which displays potent antitumour activity [11]. 
The knowledge about the chemical composition of marine organisms is an essential element for 
assessing chemotaxonomic, chemical ecology, and natural products studies, including that directed 
towards evaluating the pharmacological roles [12–20]. Recently, we initiated a program to investigate 
the hypothesis that Caulerpa species produce secondary metabolites with possible antinociceptive and 
anti-inflamatory actions. In our preliminary investigation of the crude methanolic extract and phases Mar. Drugs 2009, 7  
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from  C. racemosa we had observed an antinociceptive effect in animal models. However, 
pharmacological and chemical studies are continuing in order to characterize the mechanism(s) 
responsible(s) for the antinociceptive action and also to identify other active principles present in 
Caulerpa racemosa [21]. 
The present study was conducted to characterize caulerpin (1, Figure 1), an alkaloid isolated from 
the lipoid extracts of Caulerpa racemosa collected in the Northeast of Brazil. Caulerpin comes from a 
family of bisindole natural products, and has an extra eight-member ring between the two indole rings 
which are incorporated directly with the carbonyl group. This alkaloid show a variety of important 
biological activities already described in the literature, among which it is important to mention the 
antitumor [22], growth regulator [23] and the plant root growth stimulant properties [24], but its in vivo 
antinociceptive and antiinflamatory activities weren’t reported yet. In addition, caulerpin may also be 
classified as a compound of low toxicity [25]. However, to date there are a few investigations 
supporting the pharmacological properties of this seaweed. Thus, this study was intended to evaluate 
the antinociceptive and anti-inflammatory activities of caulerpin from Caulerpa racemosa in animal 
models.  
 
Figure 1. Structure of caulerpin (1). 
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2. Results and Discussion 
 
Three different animal models were used in this study to investigate the antinociceptive potential of 
caulerpin. These methods were selected to ensure both centrally and peripherally mediated effects were 
investigated. The acetic acid-induced abdominal constriction and the hot-plate methods analyzed 
peripheral and central activity, respectively, while the formalin test investigated both. In addition, the 
ear edema induced by capsaicin and the peritonitis induced by carrageenan in mice were used to 
examine the anti-inflammatory activity of this compound. The acetic acid-induced writhing is a 
visceral pain model and widely used for the evaluation of peripheral antinociceptive activity [26]. The 
intraperitoneal administration of an agent that irritates the serous membranes cause a stereotypical 
behavior in mice which is characterized by abdominal contractions, movements of the body as a 
whole, twisting of the dorsum abdominal muscles, and a reduction in the motor activity and 
coordination [27]. The results depicted in Figure 2 shows that caulerpin, given 40 min before, has Mar. Drugs 2009, 7  
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produced an inhibition of the acetic acid-induced abdominal constrictions in mice. The IC50 calculated 
(with 95% confidence interval) for caulerpin was 0.0945 μmol (0.0103–1.0984)   
(n = 10) and for dypirone it was 0.0426 μmol (0.0092–0.1972) (n = 10). The dates were expressed as 
% inhibition was compared to the respective acetic acid control group. The mean of contortions of the 
control group was 42.8 ± 1.9.  
Acetic acid causes an increase in the peritoneal fluid level of prostaglandins (PGE2 and PGF2α) as 
well as lipooxygenase products, involving in part peritoneal receptors and inflammatory pain by 
inducing capillary permeability [26,28]. Collier et al. [29] postulated that acetic acid acts indirectly by 
inducing the release of endogenous mediators, which stimulate the nociceptive neurons. The most 
important transmission pathways for inflammatory pain are that comprising peripheral polymodal 
nociceptors sensitive to protons, such as acid sensitive ion channels and to algogen substances, such as 
bradykinin and cytokines. Although the writhing test has poor specificity (e.g., anticholinergic, 
tricyclic antidepressants and antihistaminic and other agents show activity in this test), it is a very 
sensitive method of screening the antinociceptive effects of compounds [29–31]. 
 
Figure 2. The antinociceptive effect of caulerpin. Dose–response curves of the caulerpin 
and dypirone (100, 10, 1, 0.1 and 0.01 µmol/kg, p.o.) on the acetic acid-induced writhing 
model in mice. Each column represents the mean of six animals. Data are expressed as 
percentage of inhibition of number writhings.  
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In the hot plate test (Table 1), the treatment with morphine (15 µmol/kg, s.c.) caused a marked 
increase in the latency time of the animals at 60–150 (12.8 ± 0.4 s, 10.3 ± 0.8 s; 9.7 ± 0.7 s;   
9.7 ± 0.9 s) and caulerpin (100 µmol/kg, p.o.) caused a marked increase in the latency time of the 
animals at the times lecture 90–150 (4.6 ± 0.6, 3.8 ± 0.5, 4.0 ± 0.5).  
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Table 1. Time-course of caulerpin (100 µmol/kg, p.o.) and morphine (15 µmol/kg, s.c.) on 
thermal nociception (hot plate).  
Animal 
Group 
Dose Pretreatment
a  Post-treatment (min)
a 
(µmol/kg)  0 min  30 min  60 min  90 min  120 min  150 min 
Control  ---  1.4 ± 0.3  2.2 ± 0.6  1.8± 0.2  3.2 ± 0.3  2.8 ± 0.3  2.6 ± 0.5 
Morphine  15  6.9 ± 0.4  5.9 ± 0.3  12.8 ± 0.4** 10.3 ± 0.8**  9.7 ± 0.7**  9.7 ± 0.9** 
Caulerpin  100  1.9 ± 0.2  2.3 ± 0.6  3.3 ± 0.5  4.6 ± 0.6**  3.8 ± 0.5*  4.0 ± 0.5* 
a results represents the mean ± s.e.m. of six animals. *P < 0.05. **P < 0.01. *p < 0.05 (ANOVA 
and Dunnett tests were used to evaluate the significance levels in comparison with zero-time). 
 
The hot-plate test is commonly used to assess narcotic analgesia [32]. Although the central and 
peripheral analgesics respond by inhibiting the number of contractions provoked by chemical pain 
stimuli, only the central analgesics increase the time of response in the hot plate test [33]. These 
observations tend to suggest that caulerpin may possess centrally- and peripherally-mediated 
antinociceptive properties. The peripheral antinociceptive effect of caulerpin may be mediated via 
inhibition of cycloxygenases and/or lipoxygenases (and other inflammatory mediators), while its 
central antinociceptive action may be due its possible action as partial agonist of adrenergic, 
serotoninergic, cholinergic and dopaminergic receptors [34,35]. Proposed mechanisms of this effect 
include interation with serotoninergic receptors, because structural similarity between serotonin and 
caulerpin [36]. 
In the present study, administration of caulerpin (p.o.) did not cause motor impairment, as evaluated 
by forced locomotion in the rotarod test, contrary to diazepam (i.p.) that induced a decrease of the fall 
latency and increase the number of fall on the rotarod assay. Thus, the possibility that the 
antinociceptive effect of the compounds tested is due to any degree of motor impairment or sedation is 
improbable. 
Table 2 shows the effects of caulerpin (100 µmol/kg; p.o.) and diazepam (35.1 µmol/kg, i.p.) on the 
rotarod test from 0.5–1 h. The compound tested did not significantly alter either the fall latency or 
number of falls when compared with the saline group.  
 
Table 2. Effect of caulerpin (p.o.) and diazepam (i.p.) administration on the latency for the 
fifth fall and the number of falls from the rotarod test. 
 
 
 
 
 
 
Each value represents the mean ± S.E.M. of the 10 animals in each group. ** p < 0.01 as compared 
to both control groups. One way ANOVA followed by Newman-Keubs as the post hoc test.  
 
Treatment 
(μmol/kg) 
Fall latency (s) Number of falls (s) 
0.5 h  1 h  0.5 h  1 h 
Saline  198.0 ± 28.1  221.0 ± 19.0  0.4 ± 0.3  0.2 ± 0.2 
Caulerpin  182.3 ± 37.3  240.0 ± 0  0.9 ± 0.4  0 ± 0 
Diazepan  2.7 ± 0.6**  109.9 ± 36.7**  9.2 ± 2.2**  3.9 ± 1.4** Mar. Drugs 2009, 7  
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The formalin test in mice confirmed an antinociceptive effect (Figures 3A  and  3B). Caulerpin   
(100 µmol/kg, p.o.) caused a significant inhibition of both neurogenic (28.5%) and inflammatory 
(55.7%) phases of formalin-induced licking. The treatment with indomethacin (100 µmol/kg, p.o.) was 
able to inhibit the second phase by 50.3%. 
The formalin test is believed to represent a more valid model for clinical pain [37]. The formalin 
test is a very useful method, not only for assessing antinociceptive drugs, but also helping in the 
elucidation of the action mechanism. The neurogenic phase is probably a direct result of stimulation in 
the paw and reflects centrally mediated pain with release of substance P while the late phase is due to 
the release of histamine, serotonin, bradikynin and prostaglandins [27]. Drugs that act primarily on the 
central nervous system, such as narcotics, inhibit both phases equally while peripherally acting drugs 
such as anti-inflammatory non-steroidal (NSAID) and anti-inflammatory steroidal only inhibit the late 
phase [27,33]. Caulerpin was able to block both phases of the formalin response although the effect 
was more pronounced in the second phase. 
To investigate the anti-inflammatory activity we did the model of capsaicin-induced ear edema in 
mice, a well-characterized and largely used model of inflammation. Topical application of capsaicin 
was observed to cause a significant rise in plasma extravasations when compared to control ear in the 
same animal treated with a vehicle. This was significantly reduced by pretreatment with caulerpin, 
which had shown 55.8% of the inhibition (Figure 4). 
 
Figure 3. The antinociceptive effect of caulerpin on the formalin test. Caulerpin   
(100 µmol/kg, p.o.) and indomethacin (100 µmol/kg, p.o.), were assayed in the early-phase  
(0–5 min, panel A) or late-phase (15–30 min, panel B) of the formalin-induced nociception 
in mice. Each point represents the mean ± S.E.M. of six animals. Statistical differences 
between the treated and the control groups were evaluated by ANOVA and Dunnett tests 
and the asterisks denote the significance levels in comparison with control groups,   
*P < 0.05,**P < 0.01. 
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Figure 4. The anti-inflammatory effect of caulerpin. Caulerpin (100 μmol/kg, p.o.) and 
indomethacin (100 μmol/kg, p.o.) were evaluated on the capsaicin-induced ear edema 
model. Each column represents the mean ± SEM of five animals. The asterisks denote the 
significance levels in comparison with control groups, *P < 0.05, **P < 0.01. 
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The capsaicin-induced ear edema is a classic model used to evaluate the anti-inflammatory 
activities of compounds [276. Capsaicin (8-methyl-N-vanillyl-6-nonenamide), the pungent component 
of red peppers of the genus Capsicum, is a pharmacological tool used to evoke neurogenic acute 
inflammatory responses such as axon reflex vasodilatation, plasma extravasation, coughing, and 
painful sensitization [38,39]. The acute neurogenic inflammatory response occurs as a result of 
neuropeptide release from stimulated primary afferent neurons [40]. Capsacin activates a distinct 
subpopulation of primary sensory neurons, with somata in the dorsal root, trigeminal as well as nodose 
ganglia, which are known as transient receptor potential vanilloid 1 (TRPV1). This receptor is a non-
selective cation channel expressed in nociceptive fibres that is also activated by heat, protons and some 
endogenous substances known to be associated with tissue inflammation, particularly lipooxygenase 
products [41,42].  
In order to evaluate a possible inhibitory effect of caulerpin in cells recruitment into the peritoneal 
cavity, the carrageenan-induced peritonitis test was used (Figure 5). The positive control group showed 
increase in the numbers of leukocytes from peritoneal exudates and in the negative control group was 
not observe augment in the migration of inflammatory cells. Leukocyte cell numbers was significantly 
reduced up to 4 h after carrageenan injection in peritoneal exudates by indomethacin (72.1%) and 
caulerpin (48.3%) pretreatments, when compared to exudates from the positive control group (animal 
inject with carrageenan).  
The carrageenan-induced peritonitis test represents a well-characterised model for studies on acute 
peritoneal inflammation. The action mechanism of carrageenan on peritonitis involves synergism 
involving prostanoids, leukotriene B4 and other chemostactic agents such as C5a and IL-8, which 
promote an increase of the vasodilatation, plasmatic exudation and recruitment of leukocytes, mainly 
neutrophils [43].  
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Figure 5. The effect of caulerpin on cell migration. Culerpin (100 µmol/kg, p.o.) and 
indomethacin (100 µmol/kg, p.o.) were evaluated by the carrageenan-induced peritoneal 
inflammation test. Each point represents the mean ± S.E.M. of six animals. Statistical 
differences between the treated and the control groups were evaluated by ANOVA and 
Dunnett tests and the asterisks denote the significance levels in comparison with control 
groups, *P < 0.05, **P < 0.01.  
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To confirm the effect of the treatment of caulerpin on recruiting cells, total and differential 
leukocyte counts were determined in cytospin smears (Table 3). Experimental evidence obtained in 
this study indicates that caulerpin (100 µmol/kg, p.o.) decreases the neutrophil counts in relation to 
other leukocytes in peritoneal exudate, suggesting that it is capable of suppresses neutrophil 
recruitment to the inflammatory sites. 
 
Table 3. Profile of cellular recruitment of the treatments with caulerpin. Caulerpin   
(100 µmol/kg, p.o.) and indomethacin (100 µmol/kg, p.o.) were used in the carrageenan-
induced (2.5 mg/animal) peritoneal inflammation test. The cell number were determinated 
by optical microscopic. 
Treatment 
Percentage of cells (%) 
Polymorphonuclear Lymphocyte Monocyte Basophil 
Saline 15.5  80.0*  1.5  3.0 
Carrageenan 34.5  44.0  20.5  1.0 
Indomethacin + Carrageenan  7.0*  68.0*  21.0  4.0 
Caulerpin + Carrageenan  6.0*  63.0*  31.0*  0.0 
Each point represents the % of inhibition of the cell number versus positive control (carrageenan) 
of six animals. Statistical differences between the treated and the control groups were evaluated by 
ANOVA and Dunnett tests and the asterisks denote the significance levels in comparison with 
control groups, *P < 0.05,**P < 0.01. 
 
In this test, the results demonstrate that caulerpin reduced significantly the number of recruit cells, 
showing that this compound presents an anti-inflammatory activity in this cells recruitment model. It is 
well-known that reactive oxygen species, nitric oxide and PGE2 are considered as inflammatory 
factors, and play important roles in damage of tissues by inflammation [44]. Reactive oxygen species Mar. Drugs 2009, 7  
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and proteases produced by activated polymorphonuclear neutrophils cause or exacerbate the 
inflammatory reactions. It has been shown previously that certain prostanoids can inhibit various 
functions of the neutrophils. It has been suggested that inhibition by endogenously generated 
prostaglandins is one of the mechanisms by which the pro-inflammatory effects of the neutrophils are 
limited [45].  
Recently, a large number of different kinds of naturally occurring alkaloids with antinociceptive 
activity have been reported, such as pronuciferine, glaucine, nuciferine and pukateine [46]. Moreover, 
studies have shown that the alkaloid could present an important anti-inflammatory activity. These 
compounds can suppress antigen and mitogen-induced lymphocyte proliferation, natural-killer cell 
cytotoxicity, histamine release by mast cells, interleukin-1 (IL-1) secretion by human monocytes and 
the action of PAF on platelets [47].  
Indole, the potent pharmacophoric nucleus, has been reported to possess a wide variety of biological 
properties as anti-inflammatory, anticonvulsant, cardiovascular , antibacterial and antifungal [47,48]. 
Like caulerpin, described in this article, ajmaline, annomontine, cryptolepine, evodiamine and 
reserpine are examples of other indole alkaloids described in the literature as active in inflammation 
models [47]. 
Caulerpin also presents structural similarity with indomethacin, an indole arylacetic acid class 
nonselective cyclooxygenase (COX) inhibitor and widely prescribed NSAID. In addition to 
suppressing prostaglandin formation by inhibiting COX, indomethacin is known to possess   
COX-independent activity such as suppression of malignant transformation of embryonic fibroblasts 
and activation of the proliferator-activated receptor α and γ [49]. Indomethacin is also a known 
phospholipase A2 inhibitor [50].  
The anti-inflammatory activity of caulerpin probably involves an antioxidant effect. Serotonin was 
once reported as being able to protect biological tissues against radiation injury. This might indicates 
the capability of serotonin to interacts with or to scavenge reactive oxygen species generated by 
ionizing radiation and serotonin derivatives also possess great potential as natural antioxidants [51,52]. 
In addition, tryptophan, an indole amino acid, when exposed to oxidative stress, tryptophyl radical may 
be generated from tryptophan, with indole nitrogen as the active center. The sensitivity of tryptophan 
to oxidative stress as well as the radio protective activity of serotonin may be indicative of the 
importance of the indole moiety in free radical [51]. Moreover, indomethacin, a indole NSAID, is a 
potent scavengers of reactive oxygen species and inhibit intracellular oxidative activity and exert 
antioxidant effects in the liposome membrane [53]. 
The indole group of caulerpin probably is responsible for the antinociceptive and anti-inflammatory 
activities of this alkaloid. The mechanisms of actions of antinociceptive and anti-inflammatory of this 
substance can involve the inhibition of COX and antioxidant activity. Moreover, its central 
antinociceptive action may be due its possible action as a partial agonist of adrenergic, serotoninergic, 
cholinergic and dopaminergic receptors. However, further studies are really needed to find out the real 
mechanisms of actions of this compound, and in fact it’s already currently underway to isolate and 
characterize other active(s) principle(s). 
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3. Conclusions 
 
From the obtained results nociceptive models (the acetic acid-induced writhings and the formalin 
tests), it was noticed for the first time that caulerpin has showed a considerable antinociceptive and 
anti-inflammatory activities. In vivo inhibition of pain in the hot plate test by this compound was 
favorable, indicating that caulerpin exhibits central activity. Indeed, it was also observed in the 
formalin test that this substance exhibited a high anti-inflammatory activity, which was confirmed on 
the capsaicin-induced ear edema model and the carrageenan-induced peritonitis. However, 
pharmacological studies are continuing in order to characterize the mechanism(s) responsible for the 
antinociceptive and anti-inflammatory actions. 
 
4. Experimental 
 
4.1. Extraction and Isolation 
 
The green alga Caulerpa racemosa was collected in the coastal region of Bessa 
(7o03´52´´S/34o49´51´´), João Pessoa, Paraíba State, Brazil in April 2008. The specimen was 
identified by Dr George Emmanuel Cavalcanti de Miranda. A voucher specimen (JPB 13999) has been 
deposited in the Herbarium Lauro Pires Xavier of the Universidade Federal da Paraíba, Brazil. 
The alga was extracted with MeOH at room temperature and the extract was partitioned between 
H2O and hexane, chloroform, ethyl acetate and n-butanol. The chloroform fraction was subjected to 
separation by Sephadex LH-20 column chromatography with a 1:1 CHCl3-MeOH solvent system 
resulting in the isolation of an orange red pigment. Based on its UV, IR and NMR spectral data and 
chemical properties, it was assigned the structure of caulerpin (1). 
 
4.2. Biological Activity Tests 
 
Drugs and reagents:  The following drugs were used in this study: acetic acid and indomethacin 
(Merck), arabic gum and dipyrone (Sigma Chemical), and morphine sulphate (Dimorf-Cristalia-BR). 
A solution of formalin 2.5 % was prepared with formaldehyde (Merck) in saline (NaCl 0.9%). The 
botanical material was used as suspension in arabic gum in all the experiments.  
 
Animals: Adult male and female Swiss albino mice (20–35 g) were used in the experiments. They were 
housed in single-sex cages under a 12-h light:12-h dark cycle in a controlled temperature room   
(22 ± 2 ºC). They had free access to food and water. Groups of six animals were used in each test 
group and control animals received vehicle only. The experiments were performed after the approval 
of the protocol by the local Institutional Ethics Committee - UFAL (N º 006443/2005-78). All 
experiments were carried out in accordance with the current guidelines for the care of laboratory 
animals and the ethical guidelines for investigations of experimental pain in conscious animals [54].  
 
The Writhing test: The methods described by Koster et al. [55] were used with a few modifications. In 
brief, the selected groups of animals, consisting of six mice per dose of plant compounds or drug, were Mar. Drugs 2009, 7  
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used in the test. Animals were pretreated with caulerpin (100 µmol/kg, body wt., p.o.), Positive control 
mice groups received standard analgesics for comparison, dipyrone for 40 min prior to the i.p. 
injection of acetic acid 0.6% (0.25 mL). The negative control animals did not receive anything (saline) 
prior to the i.p. injection of acetic acid. Five minutes after the i.p. injection of acetic acid, the number 
of writhes exhibited by each mouse was counted for 20 min. The antinociceptive activity was 
expressed as the reduction on the number of abdominal writhing. 
 
The Hot-Plate Test: The hot plate test was used to measure response latency according to the method 
described by Eddy and Leimbach [56], with minor modifications. In these experiments, the hot plate 
apparatus (Ugo Basile, Model-DS 37) was maintained at 55.5 ± 1 
oC. Animals were placed on the 
heated surface and the time between placement and licking of the paws or jumping was recorded as 
latency. Latency was recorded for vehicle control groups (10 mL/kg) or pre-treated groups   
(100 μmol/kg, body wt., p.o.). The test compounds were administered after animal selection on time of 
30 min. The selection was made on the basis of the reactivity on the test. Pre-treatment times 0 and  
30 min were used for assay adaptation and selection of the animals, respectively. Only mice showing a 
reaction time within the range of 4–10 sec. were used in this test. The latency of the reaction to 
nociception was measured at time 0 and then at 30 min intervals up to the 180 min. The botanical 
materials were administered at 30 min and treatment latencies were recorded at the following time 
points: 60, 90, 120 and 150 min. 
 
The Rotarod Test: The effect of compounds on locomotor performance was tested on the rotarod 
apparatus as described previously [57]. Twenty-four hours before the experiments, all animals were 
trained in the rotarod (3.7 cm in diameter, 16 r.p.m) until they could remain in the apparatus for 60 s 
without falling. On the day of the experiment, mice were treated with caulerpin (100 μmol/kg p.o) and 
diazepam (35.1 μmol/kg, i.p) and tested in the rotarod from 0.5–1 h after their administration. The 
latency to fall and the number of fall from the apparatus were recorded with a stopwatch for up  
to 240 s. 
 
Formalin-Induced Pain in Mice:  In brief the animals were pretreated with caulerpin   
100 μmol/kg, body wt., p.o.). Positive control mice groups received standard anti-inflammatory for 
comparison, indomethacin for 40 min prior to the i.p. injection of formalin. The formalin test was 
performed according to the method of Hunskaar and Hole [58]. Briefly, 20 μL of a 2.5% (v/v) solution 
of formalin in saline were injected into the sub plantar region of the right hind paw and the 
quantification of the time that the animal spent licking the paw during the first 5 min (first phase) and 
from 15 to 30 min (second phase) of post-injection time was recorded. The test was performed at room 
temperature (22–26 ºC) and strictly actions were taken to exclude environmental disturbances (high 
temperature, noise and excessive movement) that might interfere with the animal’s response [59].  
 
Capsaicin-Induced Ear Edema in Mice: The capsaicin-induced ear edema model was performed 
according to the method of Mantione et al. [60]. Forty minutes after injection of caulerpin and 
indometacin (100 μmol/kg, body wt., p.o.), 250 μg of capsaicin were applied to the inner and other 
surface of the right ear of the mice. The control group received vehicle only (10 mL/kg, p.o.). The left Mar. Drugs 2009, 7  
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ear received acetone, delivered in the same manner. Thirty minutes after capsaicin application, the 
mice were killed and both ears were removed. Circular sections were taken, using a cork borer with a 
diameter of 6 mm, and weighed. The increase in weight caused by the irritation was measured by 
subtracting the weight of the untreated left ear section from that of the treated right ear sections. Ear 
edema was measured as the differences in weight between the treated and the untreated ear. The 
percent of inhibition was calculated by using (C-T)/C × 100 (%), where C and T indicate non-treated 
(vehicle) edema and drug-treated edema, respectively. 
 
Carrageenan-Induced Peritonitis in Mice: For this series of experiments, the method described by 
Ferrándiz and Alcaraz [61] was used. Carrageenan (Sigma Aldrich) was freshly prepared   
(10 mg/mL) in sterile 0.9% w/v saline, and 250 μL were injected i.p., After 4 hours, the animals were 
killed by cervical dislocation. The peritoneal cavity was washed with 1.5 mL cold PBS, and after a 
gentle manual massage, the exudate was retrieved and its volume was measured. The number of recruit 
leukocytes to the peritoneum was counted in a Neubauer chamber and results were expressed as   
cells × 10
6/mL. The exudate was collected and used freshly for cell counts and cytospin preparations. 
The caulerpin (100 μmol/Kg, i.p.), the carrageenan group (arabic gum, p.o.) and the reference drug 
(indomethacin, 100 µmol/kg, p.o.) were administered 30 min before the carrageenan injection. In the 
negative control group, animals have just received the same dose of a vehicle (arabic gum, p.o.) 30 min 
before the saline injection by intraperitoneal route. 
 
4.3. Statistical Analysis 
 
The levels of significance between the experimental groups and the control were made using 
ANOVA in the tutorial Prisma
®. The values were considered significant when * p < 0.05. The results 
were expressed as the average ± S.E.M of the average, as indicated in the legends in the figures. The 
value of ID50 (nonlinear regression analyses and confidence limits) were determined using the 
GraphPad Prism computer programme (GraphPad
® Software Inc.). 
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